Search research articles
Contact Us
Filters
Showing results (91-100 of 111) with videos related to
Page
of 12
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN
|
October 2, 2012
Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases
Nelson Leung, Morie Gertz, Robert A Kyle, et al.
American Journal of Hematology
|
March 7, 2026
Predicting Early Mortality in Newly Diagnosed AL Amyloidosis: Development and Validation of the PACE Score for Daratumumab-Treated Patients
George S Mellgard, Abdul-Hamid Bazarbachi, Saurabh Zanwar, et al.
American Journal of Hematology
|
June 8, 2026
Determinants of Long-Term Benefit From High Dose Melphalan With Autologous Stem Cell Transplant in AL Amyloidosis
Maximilian J Steinhardt, Ute Hegenbart, Tamer Hellou, et al.
Research Square
|
April 17, 2026
Risk of AL Amyloidosis is Associated with Degree of Free Light Chain Elevation and Duration of Exposure
Angela Dispenzieri, Maximilian Steinhardt, Eli Muchtar, et al.
Blood Cancer Journal
|
December 31, 2025
Clinical course, risk factors and mitigating strategies for Immune effector cell-associated late onset neurotoxicities after ciltacabtagene autoleucel CAR-T in multiple myeloma
Kenneth J C Lim, Melinda Tan, Ricardo Parrondo, et al.
British Journal of Haematology
|
November 20, 2020
Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma
Jithma P Abeykoon, David L Murray, Isaiah Murray, et al.
Research Square
|
March 27, 2026
Biomarkers of Cellular Senescence and their Association with Frailty, Clinical Outcomes, and Survival in Multiple Myeloma
Nadine Abdallah, Byron Smith, Thomas White, et al.
Journal of Neurology
|
July 31, 2022
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update
Thomas H Brannagan, Teresa Coelho, Annabel K Wang, et al.
Cancer Research
|
April 9, 2009
Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia
Esteban Braggio, Jonathan J Keats, Xavier Leleu, et al.
American Journal of Hematology
|
February 24, 2017
A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy
Allison Rosenthal, Amylou C Dueck, Stephen Ansell, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 111) with videos related to
Sort By:
Page
of 12
Clinical Journal of the American Society of Nephrology : CJASN
|
October 2, 2012
Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases
Nelson Leung, Morie Gertz, Robert A Kyle, et al.
American Journal of Hematology
|
March 7, 2026
Predicting Early Mortality in Newly Diagnosed AL Amyloidosis: Development and Validation of the PACE Score for Daratumumab-Treated Patients
George S Mellgard, Abdul-Hamid Bazarbachi, Saurabh Zanwar, et al.
American Journal of Hematology
|
June 8, 2026
Determinants of Long-Term Benefit From High Dose Melphalan With Autologous Stem Cell Transplant in AL Amyloidosis
Maximilian J Steinhardt, Ute Hegenbart, Tamer Hellou, et al.
Research Square
|
April 17, 2026
Risk of AL Amyloidosis is Associated with Degree of Free Light Chain Elevation and Duration of Exposure
Angela Dispenzieri, Maximilian Steinhardt, Eli Muchtar, et al.
Blood Cancer Journal
|
December 31, 2025
Clinical course, risk factors and mitigating strategies for Immune effector cell-associated late onset neurotoxicities after ciltacabtagene autoleucel CAR-T in multiple myeloma
Kenneth J C Lim, Melinda Tan, Ricardo Parrondo, et al.
British Journal of Haematology
|
November 20, 2020
Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma
Jithma P Abeykoon, David L Murray, Isaiah Murray, et al.
Research Square
|
March 27, 2026
Biomarkers of Cellular Senescence and their Association with Frailty, Clinical Outcomes, and Survival in Multiple Myeloma
Nadine Abdallah, Byron Smith, Thomas White, et al.
Journal of Neurology
|
July 31, 2022
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update
Thomas H Brannagan, Teresa Coelho, Annabel K Wang, et al.
Cancer Research
|
April 9, 2009
Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia
Esteban Braggio, Jonathan J Keats, Xavier Leleu, et al.
American Journal of Hematology
|
February 24, 2017
A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy
Allison Rosenthal, Amylou C Dueck, Stephen Ansell, et al.
Page
of 12